Shionogi Pharma, Inc. Announces FDA Approval of KAPVAY - The First and Only Therapy Approved for Use with Stimulant Medication for the Treatment of ADHD
10/4/2010 6:57:22 AM
More...
|
Shionogi Pharma, Inc. to Halve US Sales Force as Generics Hit Former Sciele Pharma, Inc. (SCRX) Business
9/8/2010 11:50:49 AM
More...
|
Shionogi Pharma, Inc.: Pivotal Data for the Investigational Treatment PSD502 for Primary Premature Ejaculation in the United States to be Presented at Major Medical Meeting
6/1/2010 8:28:48 AM
More...
|
Five Clinical Presentations Highlight Shionogi Pharma, Inc.'s PSD502, an Investigational Treatment for Primary Premature Ejaculation
5/26/2010 10:19:51 AM
More...
|